A randomized, double-blind clinical trial of a herbal formulation (GlycaCare-II) for the management of type 2 diabetes in comparison with metformin.

Diabetol Metab Syndr · 2021 · PMC8596953 · PMID 34789340

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Clinical laboratory evaluation Lipid levels The reduction in TC, TG, LDL, VLDL, and the increase in HDL was highly significant in the GlycaCare-II treated subjects.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.